NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report
Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Xeris reported 4Q19 earnings yesterday. 4Q19 EPS of $(1.23) was below FactSet consensus of $(1.13). Revenue of $1.9 mil beat our estimate of $0.8 mil. In our opinion, revenue and revenue growth trajectory are likely the dominant metrics that investors judge Xeris by during 2020. The company launched the Gvoke pre-filled syringe (PFS) during 4Q19. Early product feedback from doctors has been positive, which matches the responses on our proprietary doctor calls. Furthermore, the commercial launch of the…







